DOI: 10.1055/s-00000069

Seminars in Liver Disease

References


Evaluation of 3-V Bioscience-2640 to reduce de novo lipogenesis in subjects with characteristics of metabolic syndrome.
Accessed June 15, 2021 at:
https://ClinicalTrials.gov/show/NCT02948569

Download Bibliographical Data

Search in: